J2KBIO Balance Sheet Health
Financial Health criteria checks 5/6
J2KBIO has a total shareholder equity of ₩27.2B and total debt of ₩2.8B, which brings its debt-to-equity ratio to 10.4%. Its total assets and total liabilities are ₩34.5B and ₩7.3B respectively. J2KBIO's EBIT is ₩5.4B making its interest coverage ratio 94.5. It has cash and short-term investments of ₩15.4B.
Key information
10.4%
Debt to equity ratio
₩2.84b
Debt
| Interest coverage ratio | 94.5x |
| Cash | ₩15.43b |
| Equity | ₩27.20b |
| Total liabilities | ₩7.32b |
| Total assets | ₩34.52b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A420570's short term assets (₩25.9B) exceed its short term liabilities (₩4.7B).
Long Term Liabilities: A420570's short term assets (₩25.9B) exceed its long term liabilities (₩2.6B).
Debt to Equity History and Analysis
Debt Level: A420570 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A420570's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A420570's debt is well covered by operating cash flow (135.2%).
Interest Coverage: A420570's interest payments on its debt are well covered by EBIT (94.5x coverage).